Cargando…

SARS-CoV-2 Omicron Specific Mutations Affecting Infectivity, Fusogenicity, and Partial TMPRSS2-Independency

The COVID-19 pandemic resulted from the global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since its first appearance in 2019, new SARS-CoV-2 variants of concern (VOCs) have emerged frequently, changing the infection’s dynamic. SARS-CoV-2 infects cells via two distinc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strobelt, Romano, Broennimann, Karin, Adler, Julia, Shaul, Yosef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223509/ https://www.ncbi.nlm.nih.gov/pubmed/37243215 http://dx.doi.org/10.3390/v15051129

Ejemplares similares

The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry
por: Strobelt, Romano, et al.
Publicado: (2023)

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
por: Meng, Bo, et al.
Publicado: (2022)

Evidence for a Hepatitis B Virus Short RNA Fragment Directly Targeting the Cellular RRM2 Gene
por: Broennimann, Karin, et al.
Publicado: (2022)

Recruitment of DNA Repair MRN Complex by Intrinsically Disordered Protein Domain Fused to Cas9 Improves Efficiency of CRISPR-Mediated Genome Editing
por: Reuven, Nina, et al.
Publicado: (2019)

Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2
por: Ma, Yong, et al.
Publicado: (2023)

Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism
por: Strobelt, Romano, et al.
Publicado: (2022)

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant
por: Suzuki, Rigel, et al.
Publicado: (2022)

SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
por: Meng, Bo, et al.
Publicado: (2022)

RNR-R2 Upregulation by a Short Non-Coding Viral Transcript
por: Broennimann, Karin, et al.
Publicado: (2021)

NQO1 Binds and Supports SIRT1 Function
por: Tsvetkov, Peter, et al.
Publicado: (2021)

SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype
por: Park, Seung Bum, et al.
Publicado: (2023)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
por: Wang, Xue-Jun, et al.
Publicado: (2022)

Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
por: Qu, Panke, et al.
Publicado: (2023)

Mutation N856K in spike reduces fusogenicity and infectivity of Omicron BA.1
por: Sun, Chunyun, et al.
Publicado: (2023)

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
por: Metzdorf, Kristin, et al.
Publicado: (2023)

The C-Terminus of the PSMA3 Proteasome Subunit Preferentially Traps Intrinsically Disordered Proteins for Degradation
por: Biran, Assaf, et al.
Publicado: (2022)

Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants
por: Qu, Panke, et al.
Publicado: (2022)

SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis
por: Zhang, Yanan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
por: Xia, Shuai, et al.
Publicado: (2023)

Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
por: Qu, Panke, et al.
Publicado: (2023)

Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease
por: Stevaert, Annelies, et al.
Publicado: (2022)

Insights into Omicron’s Low Fusogenicity through In Silico Molecular Studies on Spike-Furin Interactions
por: Mondol, Spencer Mark, et al.
Publicado: (2023)

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation
por: Saito, Akatsuki, et al.
Publicado: (2021)

Encapsulated cargo internalized by fusogenic liposomes partially overlaps the endoplasmic reticulum
por: Mustata, Roxana C, et al.
Publicado: (2009)

Influence of Membrane–Fusogen Distance on the Secondary Structure of Fusogenic Coiled Coil Peptides
por: Daudey, Geert A., et al.
Publicado: (2019)

TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
por: Kishimoto, Mai, et al.
Publicado: (2021)

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
por: Zang, Ruochen, et al.
Publicado: (2020)

Host Serine Proteases TMPRSS2 and TMPRSS11D Mediate Proteolytic Activation and Trypsin-Independent Infection in Group A Rotaviruses
por: Sasaki, Michihito, et al.
Publicado: (2021)

Down syndrome: the aggravation of COVID-19 may be partially justified by the expression of TMPRSS2
por: Evangelho, Victor Gustavo Oliveira, et al.
Publicado: (2021)

Virulence Potential of Fusogenic Orthoreoviruses
por: Wong, Ann H., et al.
Publicado: (2012)

Fusogenic Viruses in Oncolytic Immunotherapy
por: Krabbe, Teresa, et al.
Publicado: (2018)

Virus and eukaryote fusogen superfamilies
por: Vance, Tyler D.R., et al.
Publicado: (2020)

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
por: Saunders, Nell, et al.
Publicado: (2022)

Potentially reduced fusogenicity of syncytin‐2 in New World monkeys
por: Shoji, Hiyori, et al.
Publicado: (2023)

Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity
por: Pal, Debnath
Publicado: (2021)

Anti-SARS-CoV-2 immunoadhesin remains effective against Omicron and other emerging variants of concern
por: Cohen-Dvashi, Hadas, et al.
Publicado: (2022)

Targeting TMPRSS2 in SARS-CoV-2 Infection
por: Baughn, Linda B., et al.
Publicado: (2020)

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
por: Zhao, Hanjun, et al.
Publicado: (2022)

Identification of potential Indonesian marine invertebrate bioactive compounds as TMPRSS2 and SARS-CoV-2 Omicron spike protein inhibitors through computational screening
por: Rizka Nurcahyaningtyas, Haviani, et al.
Publicado: (2023)

Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy
por: Adler, Julia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cbjhfhb2qhhkpm80nnlsenefn7